Immunotherapy and Immunoprevention - Molecular Vaccine Design

Hadeel Khallouf, PhD

Postdoctoral Scientist

© dkfz.de

Scientific CV

2012 - 2015
Postdoctoral scientist, Junior Research Group Immunotherapy and Immunoprevention, DKFZ, Heidelberg

2007 - 2011                       
PhD in Oncology, National Center for Tumor Diseases and University Hospital Heidelberg, Heidelberg

2005 - 2007                       
MSc in Pharmacology, Faculty of Pharmacy, University of Strasbourg, Strasbourg, France

1999 - 2004
BSc in Pharmacy and Pharmaceutical Chemistry, University of Damascus, Syria

Research Project

Development of optimal formulation and delivery systems for epitope-based therapeutic HPV vaccines

Therapeutic vaccination with defined epitopes is an attractive approach for induction of HPV-specific T lymphocyte responses. We are working with HPV epitopes that have been proven to be presented on HPV-transformed tumor cells by our highly sensitive mass spectrometry approach. This project dealt with establishing and evaluating various vaccine delivery and adjuvant formulations to determine the best vaccination methodology for targeted induction of effective anti-HPV immune responses.

Resulting Publications

Therapeutic vaccine strategies against HPV.
Khallouf H, Grabowska AK, Riemer AB.
Vaccines 2014, 2(2): 422-462.

to top
powered by webEdition CMS